Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Glaxosmithkline Plc (GSK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 94,622,280
  • Shares Outstanding, K 2,478,970
  • Annual Sales, $ 37,798 M
  • Annual Income, $ 1,236 M
  • 36-Month Beta 0.98
  • Price/Sales 2.47
  • Price/Cash Flow 9.55
  • Price/Book 14.85

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.07 +8.93%
on 12/26/17
38.32 -0.31%
on 01/19/18
+2.84 (+8.03%)
since 12/19/17
3-Month
34.52 +10.66%
on 12/06/17
40.93 -6.67%
on 10/20/17
-2.90 (-7.06%)
since 10/19/17
52-Week
34.52 +10.66%
on 12/06/17
44.53 -14.22%
on 05/31/17
-0.55 (-1.42%)
since 01/19/17

Most Recent Stories

More News
Will J&J's (JNJ) Pharma Segment Pull Up its Q4 Earnings?

J&J's (JNJ) pharma segment sales growth accelerated in the third quarter and we are likely to see, a continuation of the positive trend in the fourth quarter.

CELG : 102.65 (+0.91%)
JNJ : 147.36 (+0.30%)
MRK : 61.28 (+0.25%)
GSK : 38.20 (+0.08%)
Pharma Stock Roundup: Merck's Keytruda Shines in Study, Priority Review for Kymriah Label Expansion

Focus this week was on Merck's (MRK) data on Keytruda as well as Novartis's updates on Kymriah and its biosimilar efforts.

JNJ : 147.36 (+0.30%)
MRK : 61.28 (+0.25%)
NVS : 86.94 (+0.61%)
GILD : 80.98 (-0.23%)
PFE : 36.94 (-0.14%)
GSK : 38.20 (+0.08%)
BMY : 62.28 (+0.73%)
J&J (JNJ) Hits New 52-Week High: What's Driving the Stock?

Promising data from several pivotal studies and a rapid pipeline progress contribute to a rally in Johnson & Johnson's (JNJ) shares.

CELG : 102.65 (+0.91%)
JNJ : 147.36 (+0.30%)
ABBV : 104.64 (+0.80%)
GSK : 38.20 (+0.08%)
J&J (JNJ) to Set Pharma Q4 Earnings in Motion: What's Up?

The positive trend seen in J&J's (JNJ) pharma segment sales in Q3 is likely to continue in Q4. Strong pharma performance and contribution from acquisitions should support the top line.

JNJ : 147.36 (+0.30%)
MRK : 61.28 (+0.25%)
PFE : 36.94 (-0.14%)
GSK : 38.20 (+0.08%)
NeuroMetrix and GlaxoSmithKline Consumer Healthcare Announce Strategic Collaboration to Develop and Expand Access to Quell Wearable Pain Relief Technology

NeuroMetrix, Inc. (Nasdaq:NURO) announced today a collaboration with GlaxoSmithKline (NYSE:GSK), one of the world's largest science-led global healthcare companies, involving Quell Wearable Pain Relief...

NURO : 1.93 (-7.21%)
GSK : 38.20 (+0.08%)
3 Biotech Stocks Start Healthy in '18: Will the Rally Last?

We take a look at some biotech stocks that have witnessed an increase in their share price this year so far and look well positioned for the rest of 2018.

AGEN : 3.97 (+1.79%)
MRK : 61.28 (+0.25%)
VRTX : 157.97 (+0.50%)
NVS : 86.94 (+0.61%)
ALKS : 57.03 (+1.62%)
GSK : 38.20 (+0.08%)
Why is Puma (PBYI) Stock Up More than 150% in a Year's Time?

Puma's (PBYI) shares jump in a year's time on its cancer drug Nerlynx's approval in the United States coupled with strategic collaborations.

PBYI : 91.60 (+3.80%)
NVS : 86.94 (+0.61%)
RHHBY : 30.6900 (+0.59%)
GSK : 38.20 (+0.08%)
Glaxo's Influenza Vaccine Gets FDA Nod for Label Expansion

Glaxo's (GSK) influenza vaccine ??? Fluarix Quadrivalent receives FDA approval for label expansion.

NVS : 86.94 (+0.61%)
EXEL : 28.00 (+0.50%)
PFE : 36.94 (-0.14%)
GSK : 38.20 (+0.08%)
GSK receives FDA approval for expanded indication for FLUARIX® QUADRIVALENT (Influenza Vaccine) for persons 6 months and older

GSK [LSE/NYSE: GSK] announced today it has received approval from the US Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research expanding the indication for FLUARIX® QUADRIVALENT...

GSK : 38.20 (+0.08%)
Pharma Stock Roundup: Novo Nordisk Reveals Bid to Acquire Ablynx, Pfizer & Others at Healthcare Conference

Focus this week was on pipeline updates provided by several companies including Pfizer (PFE) at a healthcare conference while Novo Nordisk's bid to acquire Ablynx also made news.

NVO : 57.79 (+2.27%)
JNJ : 147.36 (+0.30%)
MRK : 61.28 (+0.25%)
PFE : 36.94 (-0.14%)
GSK : 38.20 (+0.08%)
SNY : 44.60 (+0.20%)
BMY : 62.28 (+0.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators mostly agree with the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Business Summary

GlaxoSmithKline is one of the world's leading research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. They also have leadership in four major therapeutic areas: anti-infectives, central...

See More

Key Turning Points

2nd Resistance Point 38.51
1st Resistance Point 38.35
Last Price 38.20
1st Support Level 38.01
2nd Support Level 37.83

See More

52-Week High 44.53
Fibonacci 61.8% 40.71
Fibonacci 50% 39.53
Fibonacci 38.2% 38.34
Last Price 38.20
52-Week Low 34.52

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.